TradesZ
Top 10 stocks to add now
← All picks
Tier L Updated July 16, 2026 · sector
The Oncology Institute, Inc. Common Stock logo

Ticker

TOI

The Oncology Institute, Inc. Common Stock

TOI — smart-money forecast & insider signals

Forecast & smart-money signals — answered with data, not hype.

66 SMART-MONEY

One insider bought $514k in 60 days; smart money shows mild conviction, not euphoria.

A factual summary of what the smart money is doing — not a buy recommendation.

🟢
Insiders are buying — 1 insider bought $514k (60d)
SEC ↗

Risk flags the hype pages skip

No going-concern / negative-equity flag

🚀 Is it really the next 10x?

✓ What resembles it

  • Oncology sector has structural tailwinds; insider buying suggests confidence in thesis.
  • Smart-money score 66/100 indicates above-average institutional interest relative to peers.
  • No major whale presence means less crowded positioning—room for early movers.

✕ What's different

  • Single insider buyer ($514k) is modest signal; no coordinated whale accumulation visible.
  • Oncology is competitive; most biotech/healthcare stocks plateau, not 10x in decade.
  • No earnings, revenue, or clinical-stage data provided—can't assess actual business momentu

Almost nothing becomes 10x; this signal means insiders see value, not destiny. Watch execution.

Get the next one before the crowd

We scan 4,000+ small-caps for exactly these smart-money signals. Free, weekly.

Send me the picks →

Overview

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Tier L — We track this ticker but don't publish active deep-dive coverage. Want us to follow it? Sign up for the newsletter and we'll look at promotion to Tier M or S if it surfaces in our pipeline.

Want our premium picks too?

Pro subscribers get our strongest pre-pop ideas + real-time buy-zone alerts.

Read more about Premium
📈
Before you buy

Before you buy anything —

See the 10 stocks our team is most bullish on right now — under-the-radar names we believe have monster upside potential, in plain English. Free.

Show me the 10 stocks — free →
Free · no credit card · unsubscribe in one click

Not investment advice. We share research and analyses for educational purposes. Investing in stocks involves risk, including possible loss of capital. Always do your own research.